Le Lézard
Classified in: Health
Subjects: NPT, EXE, PSF, AVO, MAT

Statement from Partnership for Drug-Free Kids in Response to the President's State of the Union Address and the Opioid Crisis


NEW YORK, Jan. 31, 2018 /PRNewswire-USNewswire/ -- President Donald Trump delivered the 2018 State of the Union address to the nation last night and offered Congress a detailed plan representing reforms that support his Administration's response to the country's crisis of opioid and drug addiction.

President Trump noted that "in 2016, we lost 64,000 Americans to drug overdoses: 174 deaths per day. Seven per hour. We must get much tougher on drug dealers and pushers if we are going to succeed in stopping this scourge. My Administration is committed to fighting the drug epidemic and helping get treatment for those in need. The struggle will be long and difficult ? but, as Americans always do, we will prevail."

As a nonprofit that supports families who are struggling with their son's or daughter's substance use, the Partnership for Drug-Free Kids calls for swift immediate action to address this problem. Underscoring that the White House declared a nationwide public health emergency last year in response to the opioid epidemic, what we need are substantive and concrete solutions to address this public health crisis. That is why the Partnership has devised a detailed, four-point plan to help end the opioid crisis and empower families to take action. (Read the Partnership's Action Plan in the Face of the Opioid Epidemic.)

"While we applaud the President for bringing attention to the country's opioid crisis in his State of the Union address, we are beyond the point of sounding the alarm and merely raising awareness about this critical health problem," said Chief Policy Officer for the Partnership, Marcia Lee Taylor. "Between the '2016 Surgeon General's Report on Alcohol, Drugs and Health' and the 2017 recommendations of the President's Commission on Combatting Drug Addiction and the Opioid Crisis, we know what needs to be done to address this epidemic: what we need is funding. We sincerely hope the President's upcoming budget will call for substantial funds to help treat this disease and support the millions of American families who are struggling to save their loved ones."

Last June, we were invited to testify before the President's Commission on Combating Drug Addiction and the Opioid Crisis and we emphasized that a major factor in the unacceptably high number of overdose fatalities is the tragic reality that families are unable to find the support and resources they need to help a loved one who is struggling with a substance use disorder. The treatment system is incredibly difficult to navigate and, because of the soaring costs of treatment and the stigma that still surrounds addiction, families do not necessarily reach out for help.

The Partnership has a long history in working with partners, agencies and government officials at the federal, state and local levels to ensure that collectively, we are doing everything possible to drive down the number of overdoses and overdose deaths. We must all work together to provide services to all who need them and  ensure that every family has access to support services ? while also addressing the problem farther upstream, making sure that there are sufficient prevention and intervention programs in place.   

"The demand for help, support and resources for families who are facing the opioid crisis head on is skyrocketing," said the Partnership's President and CEO, Fred Muench. "Although we have been working tirelessly to address this issue for years, the demand for comprehensive resources is overwhelming, and we simply cannot meet the needs of so many parents and families who so desperately reach out for help, day in and day out. More must be done to address this problem and these families need to be part of any solutions we bring forth."

Our Support for Families Facing the Opioid Crisis

The Partnership remains steadfast in our commitment to finding solutions to help end the opioid crisis:

The Partnership Empowers Families with Critical Information and Support

For more information, please visit drugfree.org.

About Partnership for Drug-Free Kids
Partnership for Drug-Free Kids is committed to helping families struggling with their son or daughter's substance use. We empower families with information, support and guidance to get the help their loved one needs and deserves. On our website, drugfree.org, and through our toll-free helpline (1-855-DRUGFREE), we provide families with direct support and guidance to help them address teen substance use. Finally, we build healthy communities, advocating for greater understanding and more effective programs to treat the disease of addiction. As a national nonprofit, we depend on donations from individuals, corporations, foundations and the public sector and are thankful to SAG-AFTRA and the advertising and media industries for their ongoing generosity. We are proud to receive a Four-Star rating from Charity Navigator, America's largest and most-utilized independent evaluator of charities, as well as a National Accredited Charity Seal from The Better Business Bureau's Wise Giving Alliance.

SOURCE The Partnership for Drug-Free Kids


These press releases may also interest you

at 02:05
Antech, the veterinary diagnostics company focused on partnering with veterinary professionals to predict, diagnose, and monitor wellness and disease, today announced the launch of the breakthrough in-hospital Nu.Q® Canine Cancer Test in Europe. A...

at 02:00
Red Arrow Therapeutics Inc. closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan. Participants of this round are: Beyond Next Ventures Inc.The University of Tokyo Edge Capital Partners Co., Ltd.Keio...

at 01:05
Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care...

at 01:01
Allied Market Research published a report, titled, "Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers and Implantable Cardioverter Defibrillators, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus...

at 00:49
Allied Market Research published a report, titled, "Inhaled Nitric Oxide Market by Application (Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease, Acute Respiratory Distress Syndrome, and Others): Global Opportunity Analysis and...

at 00:45
Vertex Pharmaceuticals Incorporated and TreeFrog Therapeutics today announced that Vertex has obtained an exclusive license to TreeFrog's proprietary cell manufacturing technology, C-StemTM, to optimize production...



News published on and distributed by: